Lowest Price Guaranteed
Slides
236
Last Updated
May 2025
View Count
9474
The global single cell analysis market size, valued at USD 4.29 billion in 2024, is projected to reach USD 5.08 billion in 2025 and USD 19.90 billion by 2035, representing a CAGR of 14.6% during the forecast period.
 |
Single cell analysis is an analytical method that is used to determine the property of cells, cell-to-cell variation and physiological state of cells. The availability of advanced technologies, such as next generation sequencing, chromatography and flow cytometers, made it easier to analyze cellular heterogeneity and pathways at molecular level. Single cell analysis emerged as a potential solution to understand disease mechanism and biological responses that further help develop a tailored treatment.
Contrastingly, the growing incidence of cancer across the globe has necessitated the demand for single cell analysis technologies for determining the tumor cells heterogeneity by examining its transcriptional profile. This approach will help in the identification of cancer stem cells and drug development for cancer patients. Beyond cancer, the growing application of single cell analysis in immunology, stem cell research and neurology are further fueling its demand in the upcoming years.
Driven by the emerging opportunities, the market players are actively focusing on technological innovations that can facilitate cellular analysis at a molecular level. However, the primary focus will be on high throughput screening methodologies for faster and accurate results. It is worth mentioning that in February 2025, 10X Genomics (global leader in single cell and spatial biology) announced a series of latest product innovations to consolidate its market position as the leading partner for high-performance single cell research on scale. In addition, 10X Genomics also revealed its new product roadmap for its Visium and Xenium portfolios at the Advanced in Genome Biology and Technology General Meeting.
Furthermore, in October 2024, BD announced the commercial launch of first high-throughout, robotics-compatible reagent kits that allow automation to ensure higher efficiency and consistency during single-cell discovery studies. These consistent innovations in this field is likely to maintain competitiveness for the long term, offering enormous opportunities to the single cell analysis market players for innovations.
The market report provides comprehensive information on single cell analysis companies who are currently active across various segments of the industry as mentioned in the table below.
| Key Report Attributes | Details | |
| Historical Trend | Since 2020 | |
| Forecast Period | Till 2035 | |
| Market Size 2025 | USD 5.08 Billion | |
| Market Size 2035 | USD 19.90 Billion | |
| CAGR (Till 2035) | 14.6% | |
| Type of Product |
|
|
| Type of Cell |
|
|
| Type of Workflow |
|
|
| Type of Technology |
|
|
| Application Area |
|
|
| End User |
|
|
| Geographical Regions |
|
|
| Key Companies Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
| Excel Data Packs (Complimentary) |
Available | |
One of the key objectives of the single cell analysis market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. We have provided informed estimates on the likely evolution of the market for the forecast period.
The global single cell analysis market analysis report also features the likely distribution of the current and forecasted opportunity within the market across various segments, such as type of product (consumables (reagents and assay kits), instruments (microscopes, hemocytometers, flow cytometers, next generation sequencing, PCR systems, high-content screening system, cell microarrays, single live cell imaging and automated cell counters)), type of cell (animal cell, microbial cell and human cell), type of workflow (single cell isolation & library preparation, downstream analysis and data analysis), type of technology (flow cytometry, next generation sequencing, polymerase chain reaction and mass spectrometry), application area (cancer, immunology, neurology, stem cell, non-invasive prenatal diagnosis, in-vitro fertilization and others), end user (academic and research laboratories, biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories and other end users), geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America) and leading players.
In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of industry’s evolution.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. The financial figures mentioned in this market report are in USD, unless otherwise specified.
Based on the type of product, the global market is segmented into consumables (reagents and assay kits) and instruments (microscopes, hemocytometers, flow cytometers, next generation sequencing, PCR systems, high-content screening system, cell microarrays, single live cell imaging and automated cell counters). According to single cell analysis market report, currently consumables hold the dominating position in the market by holding 53% of the overall revenue share. This can be attributed to the fact that consumables, such as reagents and assay kits are widely used in single cell analysis and essential for genetic expression and cellular functions analysis.
However, in the long run, instruments segment is expected to register a higher CAGR during the forecast period. This is primarily due to the increasing adoption of advanced high throughput technologies, such as next generation sequencing and polymerase chain reaction for analysis of cells at molecular level. Additionally, research laboratories and pharmaceutical companies use instruments for clinical studies, which is expected to be a key growth factor for this segment.
This segment highlights the distribution of global market across different types of cells, such as animal cell, microbial cell and human cell. Based on single cell market analysis, currently the human cell segment is dominating the market, and the trend is likely to remain unchanged during the forecast period. This can be attributed to the fact that human stem cells are currently being explored for the development of cell-based therapies to treat a wide range of diseases.
Additionally, human cells play a crucial role in disease diagnosis and treatment planning. In addition, the ongoing research on cancer is expected to drive the demand for human cells for determining heterogeneity. Considering the ongoing demand, this segment is likely to grow at a higher CAGR during the forecast period.
The global market is distributed across different types of workflow, such as single cell isolation & library preparation, downstream analysis and data analysis. Currently, data analysis accounts for the highest single cell analysis market share (nearly 40%). This can be attributed to the growing requirement for advanced data analytic solutions to analyze and store vast amount of data generated from single cell analysis. Computational tools, such as predictive analytical tools and computational methods offer seamless analysis of data.
However, in the future, downstream analysis segment is likely to grow at a higher CAGR during the forecast period. It is worth mentioning that single cell sequencing technologies and analysis tools are important for the extraction of insight information from complex data. Moreover, downstream analysis tools can integrate with data analysis technologies and upstream sample preparation for meaningful extraction of information. These factors collectively boost the demand for analysis tools for downstream analysis, contributing to the highest growth rate during the projected period.
The global single cell analysis market size is categorized across different type of technology, such as flow cytometry, next generation sequencing, polymerase chain reaction and mass spectrometry. Currently, flow cytometry market segment accounts for the largest share of the industry. Flow cytometry technology is highly versatile and offer high throughput which makes it essential for analyzing vast amount of data quickly generated from single cell analysis.
However, next generation sequencing technology segment is likely to register a higher CAGR during the forecast period. This can be attributed to the fact that next generation sequencing offers increased throughput and speed for data analysis, which makes it an ideal technology to explore genomic expression of single cells. With growing interest towards cell based and gene therapies, next generation sequencing technology is likely to gain momentum during the forecast period.
The global market is further segment across different application areas, such as cancer, immunology, neurology, stem cell, non-invasive prenatal diagnosis, in-vitro fertilization and other application areas. With a share of 31%, presently, cancer segment is dominating the market for single cell analysis. This can be attributed to the increasing usage of single-cell analysis for diagnostics of cancer cells and determining genetic variation via mutation rates, cell proliferation. Single cell analysis helps to plan treatment of the cancer patient based on the information collected through single cell analysis technologies, which is likely to be a key growth factor for this segment.
However, it is worth mentioning that immunology segment is likely to register a higher CAGR during the forecast period. This is primarily due to the fact that single cell analysis allows researchers to gain deep insight into immune cell population and heterogeneity. Detailed profiling of immune cells helps to understand the key differences in gene expression and disease pathogenesis.
Based on the end user, the global market is segmented into academic and research laboratories, biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories and other end users. According to single cell analysis market forecast, currently academic and research laboratories account for the highest share (71%) of the market. This is likely to be the result of increasing research initiatives by government and research organizations on genomics, cancer and infectious diseases.
However, in the future, it is expected that biotechnology and pharmaceutical companies’ segment will register a higher CAGR during the forecast period. This is potentially due to the growing research on cell-based therapies and personalized treatment. It is worth mentioning that industry players are aiming to develop next generation sequencing platforms that can facilitate single cell analysis, which will further contribute to the growth of this segment.
The global single cell analysis market size is distributed across North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. Among these, North America currently holds the highest share (39%) of the market. This is likely to be the result of the increasing incidence of cancer in this region and rising research on genomics and oncology.
However, in Asia-Pacific, the market is expected to grow at a substantial CAGR over the forecast period. This can be attributed to the increasing geriatric population with chronic conditions and rising research on advanced drugs to treat patients. Moreover, Asian countries, such as China, Japan and India are focusing on cell therapies and technological advancements that aid in analyzing large amount of data.
The “Single Cell Analysis Market: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics, and future opportunities for single cell analysis companies. The market research report lays emphasis on the consumables and instruments that are being developed. Key takeaways of the market report are briefly discussed below.
Presently, market landscape of single cell analysis companies is immensely competitive, witnessing the presence of a wide array of well-established and new entrants. The primary focus of industrial players will be on technological innovations and the integration of AI technologies to enable automation.
In order to leverage a competitive edge, several market players are focusing on partnerships and collaborations with the aim of strengthening product portfolio and services expansion. For instance, February 2025, Chan Zukerberg Initiative (CZI) in collaboration with 10x Genomics, Ultima Genomics and group of researchers launched “The Billion Cells Project”, a strategic initiative to generate one billion cell dataset to enhance progress in AI model development in biology. Upon completion, this single-cell data set will provide new resolution to multiple domains of biology.
As more market players continue to proliferate their efforts in this field, the market will continue to maintain competitiveness for a long time.
Single cell analysis market is growing rapidly driven by the increasing incidence of cancer and research on advanced cell-based therapies. Notably, high throughput technologies, such as next generation sequencing and cell cytometry enable researchers to understand the heterogeneity of tumor cells. The information collected through these technologies plays a significant role in the development of tailored treatment, which is likely to be a key growth factor for the market. In addition, the growing preferences for cell-based therapies and gene therapies to target a wide range of diseases is likely to bolster the demand for single cell analysis technologies in the future.
Despite the heightened demand, several challenges may hinder market progress during the forecast period. Some of the potential challenges include the high cost of single cell analysis instruments and technological limitations. It is worth mentioning that technological limitations, low-yielding, chances of contamination and higher rate of empty cells during analysis may limit the adoption of single cell analysis technologies. Additionally, the requirement of specialized technologies to analyze complex genomic data may enhance the overall cost of single cell analysis, which is likely to impact market growth during the forecast period.
Single cell analysis industry is witnessing a transformative shift driven by the increasing technological innovations, including high sensitivity, high throughput and speed. In addition, the market players are focusing on the development of single cell multi-omics approach that combines transcriptomics with other data sequencing approaches, such as genomics, proteomics and epigenomics. Additionally, the increasing focus on spatial genomics and transcriptomics to understand cell characterization and organization within tissue is gaining traction.
The market for single cell analysis is estimated to be valued at USD 5.08 billion in 2025 and is projected to reach USD 19.90 billion by 2035, representing a higher CAGR of 14.6% during the forecast period. The unprecedented growth is driven by the rising demand for advanced throughput technologies for single cell analysis and the latest technological advancements.
In order to enhance technological innovations, several industrial players are focusing on product portfolio and technological innovations. For instance, in November 2024, CS Genetics (global leader in next-generation single-cell genomics) announced the launch of its SimpleCell™ 3’ Gene Expression kits, which is designed for scalable single-cell transcriptomics. As more market players focus on the development of advanced kits and instruments, the market will continue to expand at a steady rate during the forecast period.
Examples of key single cell analysis companies engaged in this domain (which have also been captured in this report) include 10x Genomics, Agilent Technologies, Apogee Flow Systems, BD, Bio-Rad Laboratories, bioMérieux, Cytek Biosciences, Corning, Danaher, Fluidigm, Fluxion Biosciences, Illumina, Merck, NanoCellect Biomedical, Oxford Nanopore Technologies, Promega, Luminex, QIAGEN, Sartorius, Thermo Fisher Scientific and Takara Bio. This market report includes an easily searchable excel database of all the companies focusing on the development of single cell analysis products.
The market report presents an in-depth analysis, highlighting the capabilities of various single cell analysis companies engaged in this domain across different segments. Amongst other elements, the market report includes:
Several recent developments have taken place in the field of single cell analysis. We have outlined some of these recent initiatives below.